Bosentan decreases pulmonary vascular resistance and improves exercise capacity in acute hypoxia

Chest

Volumn 135, Issue 5, 2009, Pages 1215-1222

  Faoro, Vitalie ^a   Boldingh, Saskia ^b   Moreels, Mickael ^c   Martinez, Sarah ^a   Lamotte, Michel ^c   Unger, Philippe ^c   Brimioulle, Serge ^c   Huez, Sandrine ^c   Naeije, Robert ^a,d  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASME HOSPITAL   (Belgium)

^d Erasme Campus ^*  (Belgium)

Author keywords

Altitude; Echocardiography; Exercise; Exercise testing; Pulmonary hypertension

Indexed keywords

BOSENTAN; CARBON DIOXIDE; OXYGEN; PLACEBO;

ADULT; ARTICLE; BICYCLE ERGOMETER; CARDIOPULMONARY EXERCISE TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG INDUCED HEADACHE; ECHOCARDIOGRAPHY; EXERCISE; FACE EDEMA; FATIGUE; FEMALE; HEART OUTPUT; HEART RATE; HUMAN; HYPOXIA; LUNG VASCULAR RESISTANCE; LUNG VENTILATION; MALE; NORMAL HUMAN; OXYGEN CONSUMPTION; OXYGEN SATURATION; PRIORITY JOURNAL; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL; REST; TREATMENT DURATION;

EID: 65949118897     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2222     Document Type: Article

References (41)

1. Fulco CS, Rock PB, Cymerman A. Maximal and submaximal exercise performance at altitude. Aviat Space Environ Med 1998; 69:793-801 (Pubitemid 28365793)
2. 2 content? Am J Physiol Regul Integr Comp Physiol 2003; 284:R304-R316
3. Rubin LJ, Naeije R. Sildenafil for enhanced performance at high altitude? Ann Intern Med 2004; 141:233-235
4. Ghofrani HA, Reichenberger F, Kohstall MG, et al. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med 2004; 141:169-177
5. Faoro V, Lamotte M, Deboeck G, et al. Effects of sildenafil on hypoxic exercise capacity in normal subjects. High Alt Med Biol 2007; 8:155-163
6. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan for pulmonary arterial hypertension. N Engl J Med 2002; 346:896-903
7. Modesti PA, Vanni S, Morabito M, et al. Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study. Circulation 2006; 114:1410-1416
8. Gujic M, Houssiere A, Xhaet O, et al. Does endothelin play a role in chemoreception during acute short term hypoxia in normal men? Chest 2007; 131:1467-1472
9. Maggiorini M, Melot C, Pierre S, et al. High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 2001; 103:2078-2083
10. Grunig E, Mereles D, Hildebrandt W, et al. Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. J Am Coll Cardiol 2000; 35:980-987
11. Yamaya Y, Boogard HJ, Wagner PD, et al. Validity of pulse oximetry during maximal exercise in normoxia, hypoxia, and hyperoxia. J Appl Physiol 2002; 92:162-168
12. Christie J, Sheldahl LM, Tristani FE, et al. Determination of stroke volume and cardiac output during exercise: comparison of two-dimensional and Doppler echocardiography, Fick oximetry and thermodilution. Circulation 1987; 76:539-547
13. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984; 70:657-662 (Pubitemid 14020664)
14. Chemla D, Castelain V, Humbert M, et al. New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest 2004; 126:1313-1317
15. Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation. 3rd ed. Baltimore, MD: Lippincott Williams & Wilkins, 1999; 143-164
16. Poon CS. Analysis of linear and mildly nonlinear relationships using pooled subject data. J Appl Physiol 1988; 64:854-858
17. Winer BJ, Brown DR, Michels KM. Statistical principles in experimental design. 3rd ed. New York, NY: McGraw-Hill, 1991; 220-283
18. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351:1425-1436 (Pubitemid 39302645)
19. Fleisch M, Sütsch, Yan XW, et al. Systemic, pulmonary, and renal hemodynamic effects of endothelin ET(A/B)-receptor blockade in patients with maintained left ventricular function. J Cardiovasc Pharmacol 2000; 36:302-309
20. Ooi H, Colucci WS, Givertz MM. Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan. Circulation 2002; 106:1618-1621
21. Chen SJ, Chen IF, Meng QC, et al. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol 1995; 79:2122-2131
22. Goerre S, Wenk M, Bartsch P, et al. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation 1995; 91:359-364
23. Rey S, Corthorn J, Chacxon C, et al. Expression and immunolocalisation of endothelin peptides and its receptors, ETA and ETB, in the carotid body exposed to chronic intermittent hypoxia. J Histochem Cytochem 2007; 55:167-174
24. Chen J, He L, Liu X, et al. Effect on the endothelin receptor antagonist bosentan on chronic hypoxia-induced morphological and physiological changes in the rat carotid body. Am J Physiol Lung Cell Mol Physiol 2007; 292:L1257-L1262
25. Dantzker DR, Bower JS. Pulmonary vascular tone improves VA/Q matching in obliterative pulmonary hypertension. J Appl Physiol 1981; 51:607-613 (Pubitemid 11002800)
26. Mélot C, Hallemans R, Mols P, et al. Deleterious effects of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984; 130:612-616
27. Mélot C, Naeije R, Hallemans R, et al. Hypoxic pulmonary vasoconstriction and pulmonary gas exchange in normal man. Respir Physiol 1987; 68:11-27
28. Guazzi M, Tumminello G, Di Marco F, et al. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol 2004; 44:2339-2348
29. Faoro V, Huez S, Giltaire S, et al. Acetazolamide improves aerobic exercise capacity but not pulmonary hypertension at high altitudes. J Appl Physiol 2007; 103:1161-1165
30. Fleg JL, Piña IL, Balady GJ, et al. Assessment of functional capacity in clinical and research applications: an advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation 2000; 102:1591-1597
31. Sun XG, Hansen EJ, Oudiz R, et al. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001; 104:429-435
32. Wensel R, Opitz CF, Anker SD, et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002; 106:319-324
33. Wagner PD. Reduced maximal cardiac output at altitude: mechanisms and significance. Respir Physiol 2000; 120:1-11 (Pubitemid 30154039)
34. Reeves JT, Groves BM, Sutton JR, et al. Operation Everest II: preservation of cardiac function at extreme altitude. J Appl Physiol 1987; 63:531-539
35. Kayser B. Exercise begins and ends in the brain. Eur J Appl Physiol 2003; 90:411-419
36. Maeda S, Miyauchi T, Iemitsu M, et al. Involvement of endogenous endothelin-1 in exercise-induced redistribution of tissue blood flow: an endothelin receptor antagonist reduces the distribution. Circulation 2002; 106:2188-2193
37. Merkus D, Houweling B, Mirza A, et al. Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation. Cardiovasc Res 2003; 59:745-754
38. Wray DW, Nishiyama SK, Donato AJ, et al. Endothelin-1-mediated vasoconstriction at rest and during dynamic exercise in healthy humans. Am J Physiol Heart Circ Physiol 2007; 293:H2550-H2556
39. Naeije R, Torbicki A. More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited [editorial]. Eur Respir J 1995; 8:1445-1449
40. Allemann Y, Sartori C, Lepori M, et al. Echographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude. Am J Physiol Heart Circ Physiol 2000; 279:H2013-H2016
41. McQuillan BM, Picard MH, Leavitt M, et al. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001; 104:2797-2802